Author, as appears in the article.: Corbacho N; Mur I; Molas ME; Vidal F; Domingo P

Department: Medicina i Cirurgia

URV's Author/s: Vidal Marsal, Francisco

Keywords: Triglycerides Statins People living with hiv Obesity Dyslipidaemia Drug-drug interactions Diabetes mellitus Colesterol Cardiovascular risk Cardiovascular disease Arterial hypertension triglycerides statins obesity dyslipidaemia drug-drug interactions diabetes mellitus colesterol cardiovascular risk cardiovascular disease arterial hypertension

Abstract: © 2020 Informa UK Limited, trading as Taylor & Francis Group. ABSTARCT: Introduction: Cardiovascular disease (CVD) continues to be an essential cause of morbidity and mortality among people living with human immunodeficiency virus infection (PLWH). Since the bulk of cardiovascular risk (CVR) factors are shared between PLWH and the general population, prevention and treatment strategies are similar. However, there are CVR factors particular to PLWH, which need separate consideration. These factors are those HIV-dependent, those related to HIV-derived consequences, and combination antiretroviral therapy (cART)-dependent. Areas covered: In this review, the authors discuss the management of CVD in PLWH, with a special interest in pharmacological treatment and drug-drug interactions with cART. Expert opinion: In recent years, we have witnessed a decreased CVD morbidity and mortality in PLWH, which probably reflects an improvement in the management of CVR factors and CVD in these patients, partially thanks to new developments in antiretroviral therapy. Therefore, although there is still room for improvement, at present, the old desideratum of equaling PLWH and the general population in terms of CVD incidence and prognosis is a little closer.

Thematic Areas: Saúde coletiva Pharmacology (medical) Pharmacology & pharmacy Pharmacology Medicine (miscellaneous) Medicina iii Medicina ii Medicina i General medicine Farmacia Ciências biológicas ii

licence for use: https://creativecommons.org/licenses/by/3.0/es/

Author's mail: francesc.vidal@urv.cat

Author identifier: 0000-0002-6692-6186

Record's date: 2023-02-19

Papper version: info:eu-repo/semantics/acceptedVersion

Link to the original source: https://www.tandfonline.com/doi/full/10.1080/14656566.2020.1856075?scroll=top&needAccess=true

Licence document URL: http://repositori.urv.cat/ca/proteccio-de-dades/

Papper original source: Expert Opinion On Pharmacotherapy. (6): 743-753

APA: Corbacho N; Mur I; Molas ME; Vidal F; Domingo P (2021). The pharmacological management of cardiovascular disease in people living with HIV (PLWH). Expert Opinion On Pharmacotherapy, (6), 743-753. DOI: 10.1080/14656566.2020.1856075

Article's DOI: 10.1080/14656566.2020.1856075

Entity: Universitat Rovira i Virgili

Journal publication year: 2021

Publication Type: Journal Publications